Related Experiment Video

Updated: Aug 18, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Magnetic resonance imaging and spectroscopy in Parkinson's disease

W R Martin1

  • 1Movement Disorder Clinic, University of Alberta, Edmonton, Alberta T5G 0B7, Canada.

Advances in Neurology
|September 14, 2001
PubMed

Insights

Conventional MRI and MR spectroscopy can help differentiate Parkinson's disease (PD) from other parkinsonian syndromes. Future MR advancements promise deeper insights into PD pathology and brain metabolism.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biophysics

Background:

  • Conventional magnetic resonance (MR) imaging currently shows no definitive structural changes in Parkinson's disease (PD).
  • MR imaging and spectroscopy are crucial for differentiating PD from other neurodegenerative parkinsonian syndromes and secondary parkinsonism.
  • Distinguishing PD from disorders like multiple system atrophy (MSA) can be aided by MR spectroscopy.

Purpose of the Study:

  • To review the current and potential future roles of MR imaging and spectroscopy in Parkinson's disease research and diagnosis.
  • To highlight how evolving MR techniques can offer insights into PD pathogenesis and associated metabolic changes.

Main Methods:

  • Review of current literature on MR imaging and spectroscopy applications in PD.
  • Discussion of potential advancements in MR pulse sequences for visualizing substantia nigra pathology.
  • Exploration of MR's utility in quantifying regional iron concentrations and assessing brain energy metabolism via spectroscopy.

Main Results:

  • Conventional MR imaging is primarily useful for differential diagnosis rather than detecting intrinsic PD pathology.
  • MR spectroscopy shows promise in distinguishing PD from conditions like MSA and evaluating metabolic changes, including glutamate levels.
  • Future MR techniques may offer more detailed information on substantia nigra pathology and iron accumulation in PD.

Conclusions:

  • MR imaging and spectroscopy are valuable tools for the differential diagnosis of Parkinson's disease.
  • Advancements in MR technology are expected to enhance our understanding of PD's underlying mechanisms, including iron metabolism and energy deficits.
  • Functional MR imaging holds potential for non-invasive evaluation of basal ganglia function in PD.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Concept Videos

Nuclear Magnetic Resonance (NMR): Overview01:07

Nuclear Magnetic Resonance (NMR): Overview

Nuclear magnetic resonance (NMR) is a phenomenon exhibited by certain nuclei that can absorb characteristic radio frequency radiation under certain conditions. NMR has been extensively applied in molecular spectroscopy and medical diagnostic imaging. In both these applications, the molecule or subject under study is placed in a magnetic field and irradiated with radio frequency energy.
NMR spectroscopy generates a spectrum where the characteristic absorption frequencies of the sample are...
Applications Of NMR In Biology01:25

Applications Of NMR In Biology

Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics  for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
The...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...